Open AccessBioanalytical Assessment of Plasma Concentrations of Angiotensin-Converting Enzyme II Inhibitors and Angiotensin Receptor Blockers: A Pilot Study Among Patients Hospitalized With Acute Heart Failure
Author(s) -
Candace D. McNaughton,
Sean P. Collins,
JoAnn Lindenfeld,
Ryan D. Morrison,
J. Scott Daniels,
Thomas J. Wang
Publication year - 2019
Publication title -
american journal of therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.349
H-Index - 62
eISSN - 1536-3686
pISSN - 1075-2765
DOI - 10.1097/mjt.0000000000000990
Subject(s) - medicine , interquartile range , heart failure , diuretic , renal function , angiotensin converting enzyme , ace inhibitor , outpatient clinic , angiotensin receptor , loop diuretic , cardiology , endocrinology , angiotensin ii , urology , blood pressure
Although angiotensin-converting enzyme II inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) improve chronic heart failure (HF) outcomes, their potential harms and benefits in acute HF (AHF) is less clear.